<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03819439</url>
  </required_header>
  <id_info>
    <org_study_id>03/18/29</org_study_id>
    <nct_id>NCT03819439</nct_id>
  </id_info>
  <brief_title>Microbiome and Mycobiome Registry of Volunteers With and Without Autism Spectrum Disorder</brief_title>
  <official_title>Microbiome and Mycobiome Registry of Volunteers With and Without Autism Spectrum Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospitals Cleveland Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospitals Cleveland Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Analyze, describe, and understand how the human gut microbiome (i.e. bacteriome and
      mycobiome) and Autism Spectrum Disorder (ASD) are related.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 30, 2019</start_date>
  <completion_date type="Actual">July 23, 2019</completion_date>
  <primary_completion_date type="Actual">July 23, 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>Characterize the microbiome [bacteria and fungal community]</measure>
    <time_frame>10 years</time_frame>
    <description>Identifying relative abundance of individual bacterial and fungal members.</description>
  </primary_outcome>
  <enrollment type="Actual">74</enrollment>
  <condition>Autism Spectrum Disorder</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Microbiome and Autism Questionnaire</intervention_name>
    <description>The questionnaire will be administered to collect demographic data (i.e. sex, age, race, and ethnicity) of the volunteers. Additionally, it will ask for the volunteers to identify whether or not they have autism spectrum disorder and what other medical conditions they have and what medications (e.g. prescribed, over the counter, herbal; etc.) that they take.</description>
  </intervention>
  <biospec_retention>None Retained</biospec_retention>
  <biospec_descr>
    <textblock>
      stool samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Volunteers will or will not have a diagnosis of Autism Spectrum Disorder (ASD). Volunteers
        will be both local and national. There will be no limit to the number of volunteers who
        participate; however, we anticipate being able to enroll at least 50 volunteers within the
        first year.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Volunteers &gt; 2 years of age

          -  Able to list all medical conditions and medications when applicable.

          -  Have already donated a stool sample to BIOHMâ„¢.

        Exclusion Criteria:

          -  Volunteers &lt; 2 years of age
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospitals Cleveland Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>January 15, 2019</study_first_submitted>
  <study_first_submitted_qc>January 24, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 28, 2019</study_first_posted>
  <last_update_submitted>July 26, 2019</last_update_submitted>
  <last_update_submitted_qc>July 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospitals Cleveland Medical Center</investigator_affiliation>
    <investigator_full_name>Mahmoiud A. Ghannoum</investigator_full_name>
    <investigator_title>Director of Medical Mycology</investigator_title>
  </responsible_party>
  <keyword>autism</keyword>
  <keyword>microbiome</keyword>
  <keyword>mycobiome</keyword>
  <keyword>bacteria</keyword>
  <keyword>fungi</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Autistic Disorder</mesh_term>
    <mesh_term>Autism Spectrum Disorder</mesh_term>
    <mesh_term>Child Development Disorders, Pervasive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

